Matrix metalloproteinase (MMP)-1,-2,-3 and-9 promoter polymorphisms in colorectal cancer

被引:1
|
作者
Elander, N [1 ]
Söderkvist, P [1 ]
Fransén, K [1 ]
机构
[1] Fac Hlth Sci, Dept Biomed & Surg, Div Cell Biol, SE-58185 Linkoping, Sweden
关键词
MMP-1; MMP-2; MMP-3; MMP-9; promoter; polymorphism; colorectal cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Matrix metalloprotemases (MMPs) are a group of matrix-degrading proteins implicated in several pathological processes, e.g., invasion and metastasis in malignant diseases such as colorectal cancer (CRC). Materials and Methods: One hundred and twenty-seven CRC patients and 208 controls were genotyped for MMP-1, -2, -3 and -9 promoter polymorphisms. The genotyping was performed with PCR/primer-extension/DHPLC or PCR/RFLP. Results: The MMP-1 2G allele was significantly associated with CRC (p=0.037). No significant association between CRC and MMP-2, -3 or -9 polymorphisms was evident. The analysis of polymorphisms in the clinicopathological subgroups displayed no significant associations. Conclusion: The MMP-1 promoter polymorphism seems to affect the susceptibility to CRC, while MMP-2, -3 and -9 polymorphisms appear less likely to have any impact on CRC.
引用
收藏
页码:791 / 795
页数:5
相关论文
共 50 条
  • [41] A single nucleotide polymorphism in the matrix metalloproteinase-1 gene promoter in colorectal cancer
    Przybylowska, K
    Blasiak, J
    EXPERIMENTAL ONCOLOGY, 2002, 24 (01) : 25 - 27
  • [42] Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis
    Wang, Jiying
    Cai, Yong
    TUMOR BIOLOGY, 2012, 33 (06) : 1819 - 1828
  • [43] The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
    Mroczko, Barbara
    Groblewska, Magdalena
    Okulczyk, Bogna
    Kedra, Boguslaw
    Szmitkowski, Maciej
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (10) : 1177 - 1184
  • [44] The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke
    Kurzepa, Jacek
    Kurzepa, Joanna
    Golab, Piotr
    Czerska, Sara
    Bielewicz, Joanna
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (10) : 707 - 716
  • [45] The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
    Barbara Mroczko
    Magdalena Groblewska
    Bogna Okulczyk
    Bogusław Kędra
    Maciej Szmitkowski
    International Journal of Colorectal Disease, 2010, 25 : 1177 - 1184
  • [46] Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients
    Singh, Ranjana
    Srivastava, Priyanka
    Srivastava, Aneesh
    Mittal, Rama Devi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (10) : 3393 - 3401
  • [47] Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects
    McColgan, Peter
    Sharma, Pankaj
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (06) : 1473 - 1478
  • [48] A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer
    Xu, E
    Lai, MD
    Lv, B
    Xing, XM
    Huang, Q
    Xia, XP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (03) : 999 - 1003
  • [49] Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients
    Irena Ranogajec
    Jasminka Jakić-Razumović
    Velibor Puzović
    Jelka Gabrilovac
    Medical Oncology, 2012, 29 : 561 - 569
  • [50] Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
    E T Waas
    R M L M Lomme
    J DeGroot
    Th Wobbes
    T Hendriks
    British Journal of Cancer, 2002, 86 : 1876 - 1883